Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 January 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

Date

Maanantai, 8 tammikuu 2024, Koko päivä
Torstai, 11 tammikuu 2024, Koko päivä

Paikka

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page